Hua Medicine
China - ShanghaiBiotechnology
Focus: Hua Medicine is a Shanghai-based public biotech company specializing in small-molecule therapeutics across metabolic diseases, respiratory, neurology, infectious diseases, and oncology. The company operates at early-to-mid stage development with a diversified pipeline.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Hua Medicine
AI assessmentNot HiringNo open roles listed right now. Follow Hua Medicine to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Dorzagliatin tablets
Stable
Growth
Phase 4 program in a high-market-value indication with potential regulatory approval and market entry potential.
Telbivudine
Help build intelligence for Hua Medicine
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.